Stay updated on Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial
Sign up to get notified when there's something new on the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page.

Latest updates to the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page
- Check7 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry v3.5.0 was added to the record history, and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision v3.4.3 was added to the page history. Revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe Record History shows multiple submissions updating study status, recruitment status, and core study details such as eligibility criteria, locations, and outcome measures.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page history now includes revision v3.4.2 and removes the previous revision v3.4.1.SummaryDifference0.1%

- Check79 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page.